For all of the quality care it delivers, the U.S. health care system is one of the most dysfunctional sectors of the U.S. economy. The government spends nearly 50 cents of every dollar spent on health care, most consumers are almost entirely insulated from the cost of their decisions, and employers decide what kind of health insurance their employees get.
But while the U.S. health care system begs for reform, the Patient Protection and Affordable Care Act only exacerbates all of the current problems, promising to devolve into a price-controlled system rationed and micromanaged by bureaucrats.
IPI believes there are much better options: reform the tax treatment of health insurance; remove the state and federal mandates and regulations that make coverage more expensive; pass medical liability reform; and promote policies that create value-conscious shoppers in the health care marketplace.
This year has been labeled a referendum on just about everything, but healthcare is one thing that will definitely drive people to the polls.
It's really hard finding a silver lining to the coronavirus outbreak and the government's response, but maybe there will be hundreds of thousands of fewer cases of the cold and flu.
Bernie Sanders claims government-run health care is more efficient, but he never addresses the rampant fraud in the two biggest government health care programs: Medicare and Medicaid.
By reintroducing his rebate rule, President Trump could lower drug prices by excluding the middlemen who gobble up much of the current price-discount savings.
If the president doesn't want to import price-controlled, foreign-made steel, then why does he want to import price-controlled prescription drugs?
Being a disrupter could be either positive or negative, depending on whether and how a voter thinks the country needs disrupting.
Efforts to control prescription-drug prices by setting prices through a government mandate are not likely to control overall prescription-drug spending.
Governments can't act as quickly as private sector drug companies when it comes to finding a vaccine for the coronavirus or any other epidemic.
President Trump and many in Congress want to reduce prescription drug prices. This paper discusses how drug prices are determined and explains why political efforts to reduce them would be both harmful and counterproductive.